What is the recommended dose and administration of albumin (human albumin) after paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Administration After Paracentesis

For large-volume paracentesis (>5 liters), albumin should be administered at a dose of 6-8 grams per liter of ascitic fluid removed to prevent paracentesis-induced circulatory dysfunction. 1, 2

Dosing Guidelines

Volume-Based Approach

  • Large-volume paracentesis (>5 liters): 6-8 g albumin per liter of ascitic fluid removed 2, 1
  • Small-volume paracentesis (<5 liters):
    • Some guidelines suggest synthetic plasma expanders may be sufficient 1
    • However, many experts recommend considering albumin even for smaller volumes to ensure safety 1

Standardized Dosing Protocol

A practical standardized approach that has been validated in clinical practice 3:

  • 25 g albumin for 5-6 liters removed
  • 50 g albumin for 7-10 liters removed
  • 75 g albumin for >10 liters removed

Timing of Administration

  • Albumin should be administered intravenously immediately after the paracentesis procedure is completed
  • Some centers divide the dose, giving half immediately after paracentesis and half 6-8 hours later, though there is no strong evidence supporting this approach over a single administration

Rationale for Albumin Administration

Albumin administration after large-volume paracentesis has been shown to:

  1. Prevent paracentesis-induced circulatory dysfunction (PICD) 2, 1
  2. Reduce the risk of hyponatremia by 42% 1
  3. Decrease mortality by 36% 1
  4. Prevent renal impairment 2

PICD is characterized by an increase in plasma renin activity >50% of pre-treatment values 4-6 days after paracentesis and may develop in up to 80% of patients without volume expansion 1.

Alternative Approaches

Lower Albumin Dosing

Some studies have investigated using lower doses of albumin (4 g/L of ascitic fluid removed) with promising results 4, 5. However, these are smaller pilot studies, and the standard 6-8 g/L remains the recommended dose based on more robust evidence.

Alternative Volume Expanders

  • Non-albumin plasma expanders (dextran, hydroxyethylstarch, gelatin) have been studied but are less effective than albumin in preventing PICD 1
  • Vasoconstrictors:
    • Midodrine has been studied but was found to be less effective than albumin in preventing PICD 6, 7
    • Terlipressin may have some efficacy but is not currently available in the United States 2

Common Pitfalls and Caveats

  1. Underestimating volume removed: Ensure accurate measurement of ascitic fluid volume to calculate the correct albumin dose
  2. Delaying albumin administration: Albumin should be given immediately after paracentesis
  3. Overlooking sodium restriction: Patients should maintain a low-sodium diet (≤5 g/day) even after paracentesis 1
  4. Forgetting to restart diuretics: Diuretics should be restarted within 1-2 days after paracentesis to prevent rapid reaccumulation of ascites 1
  5. Ignoring beta-blocker considerations: In patients with refractory ascites, non-selective beta-blockers may need to be suspended as they can increase the frequency of PICD 1

Special Considerations

  • Cost concerns: Albumin is expensive, which has driven research into lower-dose protocols and alternatives. However, the clinical benefits of standard dosing (6-8 g/L) outweigh the cost considerations for most patients
  • Patients with spontaneous bacterial peritonitis: These patients require a different albumin regimen (1.5 g/kg at diagnosis and 1 g/kg at day 3) 2
  • Limiting paracentesis volume: Consider limiting single paracentesis sessions to <8 liters as the risk of PICD increases with larger volumes 1

By following these evidence-based guidelines for albumin administration after paracentesis, clinicians can minimize the risk of complications and improve outcomes in patients with cirrhotic ascites.

References

Guideline

Management of Circulatory Dysfunction after Paracentesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Research

Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.

Liver international : official journal of the International Association for the Study of the Liver, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.